Genetics of Uveitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorThe Cleveland Clinic
About this trial
In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.
Eligibility criteria
Qualifiers
Any patient above with the diagnosis of uveitis.
Any patient with a diagnosis of infectious uveitis such as toxoplasmosis retinochoroiditis, herpes associated retinitis.
Disqualifiers
Patients who are unable to give consent
Patients in whom an adequated blood sample can not be obtained.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,500 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov